StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
GSAC

GelStat Corporation

GSAC Pharmaceutical Preparations EDGAR ↗
$0.00
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
Revenue (TTM)
Net income (TTM)
EPS (TTM)
P/E ratio
Dividend yield
Free cash flow
Cash
Total assets
Gross margin
52-week range
$0.00 – $0.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-K/A Fiscal year ended 2008-12-31 Nov 21, 2012 10-K/A Fiscal year ended 2007-12-31 Nov 21, 2012 10-K Fiscal year ended 2008-12-31 Oct 22, 2012 10-Q Quarter ended 2008-09-30 Oct 22, 2012 10-Q Quarter ended 2008-06-30 Oct 22, 2012 10-Q Quarter ended 2008-03-31 Oct 22, 2012 10-K Fiscal year ended 2007-12-31 Oct 22, 2012 10-Q Quarter ended 2007-09-30 Oct 22, 2012 10-Q Quarter ended 2007-06-30 Oct 22, 2012 10-Q Quarter ended 2007-03-31 Oct 22, 2012 10-K Fiscal year ended 2006-12-31 Oct 19, 2012 10-Q Quarter ended 2006-09-30 Oct 19, 2012 10-Q Quarter ended 2006-06-30 Oct 19, 2012 10-Q Quarter ended 2006-03-31 Oct 18, 2012 10-K Fiscal year ended 2005-12-31 Oct 5, 2012 8-K Director or officer change May 2, 2007 8-K Director or officer change Jun 28, 2006 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Director or officer change Jun 19, 2006 8-K Director or officer change Mar 21, 2006 8-K Director or officer change Jan 31, 2006 8-K Entered a material agreement Jan 3, 2006 8-K Other events Nov 17, 2005 8-K Completed an acquisition or disposition Nov 16, 2005 8-K Director or officer change Jul 22, 2005 8-K Director or officer change May 5, 2005 8-K Entered a material agreement Jan 12, 2005 8-K Other events Dec 15, 2004 8-K Director or officer change Oct 19, 2004 8-K Director or officer change Sep 28, 2004 8-K Item 5; Item 7 Jul 22, 2004 8-K/A Item 4; Item 7 Feb 9, 2004 8-K Item 4; Item 7 Jan 9, 2004 8-K Item 5; Item 7 Sep 25, 2003 8-K Item 5; Item 7 Aug 1, 2003 8-K/A Item 2; Item 7 Jul 15, 2003 8-K/A Item 2; Item 7 Jul 14, 2003 8-K Item 1; Item 2 May 9, 2003 8-K Item 5; Item 7 Nov 29, 2002 8-K/A Item 4; Item 7 Aug 26, 2002 8-K Item 4 Aug 14, 2002